U.S. Machinery Stock News

RedCloud Holdings (NasdaqCM:RCT) just posted its H1 2025 scorecard, with trailing twelve month revenue of about $48.4 million and a basic EPS of roughly -$1.76. This sets a clear backdrop of rapid top line expansion paired with ongoing losses. The company has seen revenue move from $13.6 million in H2 2023 to $16.1 million in H1 2024 and then $30.4 million in H2 2024. Over those same halves, EPS shifted from about -$4.20 to -$0.51 and then a much steeper -$17.85. That combination of fast...

Vail Resorts (MTN) opened fiscal Q1 2026 with revenue of about $271 million, a basic EPS loss of roughly $5.20, and net income excluding extra items of around negative $187 million, setting a cautious tone for the new season. The company has seen quarterly revenue move from about $260 million in Q1 2025 to roughly $271 million in Q1 2026, while basic EPS shifted from a loss of about $4.62 to a loss of roughly $5.20 over the same period, giving investors a mixed read on top line stability...

If you have been wondering whether SkyWest at around $107 a share is still good value after its big comeback, you are not alone. This article is designed to walk you through that question step by step. The stock has climbed 5.2% over the last week, 10.6% over the past month, and 495.2% over three years, which naturally raises the question of how much upside, or downside, might be left from here. Recently, investors have been focused on SkyWest’s progress in rebuilding regional capacity and...

Manchester United (NYSE:MANU) opened Q1 2026 with revenue of about £140.3 million and a basic EPS of roughly -£0.04, alongside net income of around -£6.6 million, keeping the club in loss-making territory even as it reports another busy quarter of activity. The club has seen quarterly revenue move between roughly £143.1 million and £198.7 million over the past year while EPS has swung from £0.01 to as low as about -£0.16, which sets up a narrative where a growing top line and negative EPS...

Synopsys (SNPS) just wrapped up FY 2025 with fourth quarter revenue of about $2.3 billion and basic EPS of $2.42, capping a year in which trailing 12 month revenue reached roughly $7.1 billion and EPS came in at $8.15. The company has seen quarterly revenue move from about $1.6 billion in the fourth quarter of FY 2024 to $2.3 billion in the latest quarter, while basic EPS shifted from $1.81 to $2.42 over the same period. This sets up a story in which investors will be weighing headline growth...

Exzeo Group (XZO) just posted Q3 2025 results with revenue of about $56.3 million, basic EPS of $0.25 and net income of roughly $21.2 million, marking another solid quarterly print. The company has seen revenue climb from $29.3 million in Q3 2024 to $56.3 million in Q3 2025, while basic EPS moved from $0.06 to $0.25 over the same period. This sets up a story of scaling profits and expanding margins that investors will be keen to track. See our full analysis for Exzeo Group. With the latest...

Oxford Industries (OXM) just turned in a messy Q3 2026, with revenue of about $307 million and a basic EPS of roughly -$4.28, while trailing twelve month figures show revenue of about $1.5 billion and basic EPS hovering around -$0.19 as the business works through a choppy earnings patch. The company has seen quarterly revenue move from roughly $308 million in Q3 2025 to $307 million in Q3 2026, alongside a swing in basic EPS from about -$0.25 to -$4.28, leaving investors focused on how much...

If you are wondering whether Borr Drilling still offers value after its recent run, or if the easy money has already been made, you are in the right place. The stock has climbed about 13.7% over the last week and 34.3% in the past month, while still sitting on a 122.1% gain over five years. This naturally raises questions about the balance between potential upside and risk from here. Recent moves have been driven by improving sentiment around offshore drilling and tightening jack up rig...

If you are wondering whether Surgery Partners is a quietly mispriced opportunity or a value trap in the making, you are not alone. That is exactly what we are going to unpack here. The stock is down 4.9% over the last week and 22.4% year to date, but a 5.0% gain over the past month hints that sentiment may be starting to shift after a long 5 year slide of 42.3%. Recent headlines have focused on Surgery Partners expanding its network of ambulatory surgery centers and deepening relationships...

Wondering whether Civitas Resources is a value play or a value trap at today’s price? You are not alone. This stock has quietly shifted from market favorite to contrarian idea. The share price has bounced about 10.5% over the last month but is still down roughly 36.4% year to date and 33.8% over the last year, a mix that often signals either a looming problem or a mispriced opportunity. Recent headlines around Civitas have focused on its portfolio positioning and capital discipline in a...

After the Chairman of the Board moved to sell a sizable block of shares, MGP Ingredients (MGPI) quickly drew fresh scrutiny as investors weighed this signal against already weakening sales and margin pressure. See our latest analysis for MGP Ingredients. The share sale comes after a rough stretch, with the share price down sharply on a year to date basis and multi year total shareholder returns deeply negative. However, this week’s double digit 7 day share price return hints at traders...

Phreesia (PHR) just posted its latest quarterly scorecard with Q2 2026 revenue of about $117 million and basic EPS of $0.01, setting a clearer snapshot of where the business stands on its path toward profitability. The company has seen revenue move from roughly $102 million in Q2 2025 to $117 million in Q2 2026, while quarterly EPS has shifted from a loss of about $0.31 to a modest profit, giving investors fresh data on how quickly margins might be stabilizing from here. See our full analysis...

If you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right...

If you are wondering whether Heidrick & Struggles International is still a smart buy after such a strong run, you are not alone. This is exactly what we are going to unpack here. The stock has climbed 33.9% year to date and is up 30.4% over the last year, while longer term holders have seen gains of 108.8% over 3 years and 122.8% over 5 years, all from a recent close of $59.01. Those gains have come as investors have warmed to the company’s positioning in higher value advisory and leadership...

As the U.S. market navigates a complex landscape with the Dow Jones Industrial Average reaching new heights and tech-heavy indices like the Nasdaq and S&P 500 experiencing pullbacks, investors are closely watching for opportunities amid fluctuating interest rates and economic data. In this environment, identifying stocks that may be undervalued requires careful consideration of their intrinsic worth relative to current market conditions, offering potential value in a diverse portfolio.

The U.S. stock market has been experiencing mixed movements, with the Dow Jones Industrial Average recently setting a new all-time high while the Nasdaq and S&P 500 have pulled back due to concerns over tech stocks. Despite these fluctuations, certain investment opportunities continue to capture attention, particularly in areas that offer affordability and potential growth. Penny stocks, though an outdated term, still represent smaller or newer companies that can provide significant value...

BillionToOne (BLLN) has just put another big quarter on the board, with Q3 2025 revenue at about $62.8 million and Basic EPS of roughly -$0.20, as investors gauge how fast the top line can outrun still negative earnings. The company has seen revenue move from roughly $34.5 million in early 2024 to about $41.7 million later that year and then to $62.8 million in 2025, while Basic EPS shifted from about -$0.76 to -$1.30 and then to -$0.20 over the same stretch, setting up a story where rapid...

Wondering if Ingevity at around $58.83 is still a smart buy or if the easy money has already been made? You are not alone; this stock has quietly been drawing fresh attention from value focused investors. After a tough few years, the share price has surged, up 12.6% over the last week, 18.8% over the past month, and 48.8% year to date, even though the 3 and 5 year returns are still down 15.5% and 19.7% respectively. Part of this turnaround story reflects shifting sentiment around specialty...

If you are wondering whether Tapestry is still a buy after its big run, you are not alone. This stock has become a litmus test for how investors value premium brands in a changing consumer landscape. The share price has been on a tear, up 5.2% over the last week, 11.0% over the last month, and 79.4% year to date, capping off a 92.0% 1-year gain and multi-year returns north of 200%. Much of that momentum has been tied to headlines around Tapestry's portfolio strategy and brand investments,...

We wouldn't blame KKR Real Estate Finance Trust Inc. ( NYSE:KREF ) shareholders if they were a little worried about the...

Wondering if Ouster's huge run means you are late to the party or staring at an overlooked opportunity? Let's break down what the market is really pricing in here. The stock is up 108.3% year to date and 181.4% over the last year, even after a recent 1.0% dip over 7 days and a modest 3.7% gain across 30 days. This hints that sentiment has shifted fast, and risk perceptions are clearly changing. Much of this excitement has been driven by Ouster's push to scale its lidar technology into...

It looks like Merck & Co., Inc. ( NYSE:MRK ) is about to go ex-dividend in the next three days. The ex-dividend date...

Passive investing in index funds can generate returns that roughly match the overall market. But the truth is, you can...

We wouldn't blame Guardant Health, Inc. ( NASDAQ:GH ) shareholders if they were a little worried about the fact that...